Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Petsuksiri, Janjira ^a   Sermsree, Achariyaporn ^a,b   Thephamongkhol, Kullathorn ^a   Keskool, Phawin ^a   Thongyai, Kanthong ^a   Chansilpa, Yaowalak ^a   Pattaranutaporn, Pittayapoom ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Ubonratchathani Cancer Center   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUDITORY CANAL; BONE CONDUCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; PERCEPTION DEAFNESS; RADIATION DOSE; RETROSPECTIVE STUDY; ADJUVANT THERAPY; ADOLESCENT; ALGORITHM; CARCINOMA; CHEMICALLY INDUCED DISORDER; EVALUATION; INCIDENCE; INNER EAR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; RADIATION EXPOSURE;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COHORT STUDIES; COMBINED MODALITY THERAPY; EAR, INNER; HEARING LOSS, SENSORINEURAL; HUMANS; INCIDENCE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79951568086     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-19     Document Type: Article

References (22)

1. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998, 16(4):1310-1317.
2. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005, 23(27):6730-6738. 10.1200/JCO.2005.16.790, 16170180.
3. Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol 2002, 25(3):219-223. 10.1097/00000421-200206000-00002, 12040275.
4. Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 2006, 106(4):820-829. 10.1002/cncr.21683, 16421885.
5. Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 2009, 73(5):1335-1342. 10.1016/j.ijrobp.2008.07.034, 18922648.
6. Herrmann F, Dorr W, Muller R, Herrmann T. A prospective study on radiation-induced changes in hearing function. Int J Radiat Oncol Biol Phys 2006, 65(5):1338-1344. 10.1016/j.ijrobp.2006.03.032, 16863923.
7. Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2005, 61(5):1393-1402. 10.1016/j.ijrobp.2004.08.019, 15817342.
8. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009, 27(22):3684-3690. 10.1200/JCO.2008.19.9109, 2720082, 19564532.
9. Raaijmakers E, Engelen AM. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol 2002, 65(1):1-7. 10.1016/S0167-8140(02)00211-6, 12413668.
10. Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, Au DK, Wu PM, Choy DT. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 1996, 36(2):281-289. 10.1016/S0360-3016(96)00302-1, 8892450.
11. Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, Mendenhall WM. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S50-57.
12. Ho WK, Wei WI, Kwong DL, Sham JS, Tai PT, Yuen AP, Au DK. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study. Head Neck 1999, 21(6):547-553. 10.1002/(SICI)1097-0347(199909)21:6<547::AID-HED8>3.0.CO;2-Y, 10449671.
13. Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003, 29(5):417-430. 10.1016/S0305-7372(03)00066-5, 12972360.
14. Low WK, Tan MG, Chua AW, Sun L, Wang DY. 12th Yahya Cohen Memorial Lecture: The cellular and molecular basis of radiation-induced sensori-neural hearing loss. Ann Acad Med Singapore 2009, 38(1):91-94.
15. Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007, 67(2):469-479. 10.1016/j.ijrobp.2006.09.017, 17236969.
16. Honore HB, Bentzen SM, Moller K, Grau C. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 2002, 65(1):9-16. 10.1016/S0167-8140(02)00173-1, 12413669.
17. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2009, 73(3):779-788. 10.1016/j.ijrobp.2008.05.040, 18707819.
18. Low WK, Burgess R, Fong KW, Wang DY. Effect of radiotherapy on retro-cochlear auditory pathways. Laryngoscope 2005, 115(10):1823-1826. 10.1097/01.mlg.0000175061.59315.58, 16222203.
19. Oh YT, Kim CH, Choi JH, Kang SH, Chun M. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 2004, 72(1):79-82. 10.1016/j.radonc.2004.02.009, 15236878.
20. Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol 2006, 24(12):1904-1909. 10.1200/JCO.2005.05.0096, 16622266.
21. Skinner R, Pearson AD, Amineddine HA, Mathias DB, Craft AW. Ototoxicity of cisplatinum in children and adolescents. Br J Cancer 1990, 61(6):927-931. 10.1038/bjc.1990.208, 1971678, 2372498.
22. Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH, Dreschler WA, Balm AJ. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis. Int J Radiat Oncol Biol Phys 2007, 68(5):1320-1325. 10.1016/j.ijrobp.2007.01.042, 17418969.